Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset.

Russo, Roberto; Gasparini, Giulia; Cozzani, Emanuele; D'Agostino, Federica; Parodi, Aurora

Russo, Roberto; Gasparini, Giulia; Cozzani, Emanuele; D'Agostino, Federica; Parodi, Aurora.

Russo R; Dipartimento di Scienze della Salute (DISSAL), Section of Dermatology, University of Genoa, Genoa, Italy.
Gasparini G; Department of Dermatology, San Martino Polyclinic Hospital, Genoa, Italy.
Cozzani E; Dipartimento di Scienze della Salute (DISSAL), Section of Dermatology, University of Genoa, Genoa, Italy.
D'Agostino F; Department of Dermatology, San Martino Polyclinic Hospital, Genoa, Italy.
Parodi A; Dipartimento di Scienze della Salute (DISSAL), Section of Dermatology, University of Genoa, Genoa, Italy.

Front Immunol ; 13: 834316, 2022.

Article in English | MEDLINE | ID: covidwho-1731783

Subject(s)

Autoimmune Diseases/immunology; COVID-19 Vaccines/immunology; COVID-19/immunology; Pemphigoid, Bullous/immunology; Aged; Humans; Male; Vaccination/methods

Keywords

COVID-19; autoimmune bullous diseases; bullous pemphigoid; pemphigus vulgaris; vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Pemphigoid, Bullous / COVID-19 Vaccines / COVID-19 Type of study: Case report Topics: Vaccines Limits: Aged / Humans / Male Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.834316

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google